ArticleAccounts of chemical research2015
Toward the synthesis of more reactive S = 2 non-heme oxoiron(IV) complexes.
Article in Accounts of chemical research, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 77 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
77 citing papers in PubMed.
- Identifying a Terminal Nickel-Oxygen Complex Bearing an Unsymmetrical β‑Diketiminate Ligand.JACS Au · 2026Article
- Activation of the Ground and Excited State of a Luminescent Osmium(VI) Dioxo Dicyano Complex with Lewis Acids.Journal of the American Chemical Society · 2026Article
- Metal-metalChemical science · 2026Article
- High-Valent Late Transition Metal-Oxo Complexes: Breaking Boundaries at the Oxo Wall and Beyond.Chemical reviews · 2026Review
- Review
- Million-Fold Activation of C-H Bonds by Fluorinated Nonheme FeACS catalysis · 2025Article
- Metal-α-Helix Peptide Frameworks.Journal of the American Chemical Society · 2025Article
- Experimental electronic structures of the FeProceedings of the National Academy of Sciences of the United States of America · 2025Article
- 10-Fold Increase in Hydrogen Atom Transfer Reactivity for a Series ofJournal of the American Chemical Society · 2025Article
- Chemical methods to stabilize segments of metalloproteins in the form of peptides.Methods in enzymology · 2025Article
- Experimental Definition of theJournal of the American Chemical Society · 2024Article
- The spin-forbidden transition in iron(IV)-oxo catalysts relevant to two-state reactivity.Science advances · 2024Article
- Total synthesis of naturally occurring abietane diterpenoidsRSC advances · 2024Article
- Enhanced Reactivities of Iron(IV)-Oxo Porphyrin Species in Oxidation Reactions Promoted by Intramolecular Hydrogen-Bonding.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024Article
- Iron-Catalyzed C-H Oxygenation Using Perchlorate Enabled by Secondary Sphere Hydrogen Bonds.Journal of the American Chemical Society · 2024Article
- Redox Processes Involving Oxygen: The Surprising Influence of Redox-Inactive Lewis Acids.JACS Au · 2024Review
- NMR and Mössbauer Studies Reveal a Temperature-Dependent Switch fromJournal of the American Chemical Society · 2024Article
- A high-spin alkylperoxo-iron(iii) complex withChemical science · 2024Article
- Enhancing the high-spin reactivity in C-H bond activation by Iron (IV)-Oxo species: insights from paclitaxel hydroxylation by CYP2C8.Frontiers in chemistry · 2024Article
- Nonheme FeInorganic chemistry · 2023Article
17 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
2003 marked a banner year in the bioinorganic chemistry of mononuclear non-heme iron enzymes. The first non-heme oxoiron(IV) intermediate (called J) was trapped and characterized by Bollinger and Krebs in the catalytic cycle of taurine dioxygenase (TauD), and the first crystal structure of a synthetic non-heme oxoiron(IV) complex was reported by Münck, Nam, and Que. These results stimulated inorganic chemists to synthesize related oxoiron(IV) complexes to shed light on the electronic structures and spectroscopic properties of these novel intermediates and gain mechanistic insights into their function in biology. All of the biological oxoiron(IV) intermediates discovered since 2003 have an S = 2 ground spin state, while over 90% of the 60 or so synthetic oxoiron(IV) complexes reported to date have an S = 1 ground spin state. This difference in electronic structure has fueled an interest to more accurately model these enzymatic intermediates and synthesize S = 2 oxoiron(IV) complexes. This Account follows up on a previous Account (Acc. Chem. Res. 2007, 40, 493) that provided a perspective on the early developments in this field up to 2007 and details our group's efforts in the development of synthetic strategies to obtain oxoiron(IV) complexes with an S = 2 ground state. Upon inspection of a qualitative d-orbital splitting diagram for a d(4) metal-oxo center, it becomes evident that the key to achieving an S = 2 ground state is to decrease the energy gap between the dx(2)-y(2) and dxy orbitals. Described below are two different synthetic strategies we used to accomplish this goal. The first strategy took advantage of the realization that the dx(2)-y(2) and dxy orbitals become degenerate in a C3-symmetric ligand environment. Thus, by employing bulky tripodal ligands, trigonal-bipyramidal S = 2 oxoiron(IV) complexes were obtained. However, substrate access to the oxoiron(IV) center was hindered by the bulky ligands, and the complexes showed limited ability to cleave substrate C-H bonds. The second strategy entailed introducing weaker-field equatorial ligands in six-coordinate oxoiron(IV) complexes to decrease the dx(2)-y(2)/dxy energy gap to the point where the S = 2 ground state is favored. These pseudo-octahedral S = 2 oxoiron(IV) complexes exhibit high H-atom transfer reactivity relative to their S = 1 counterparts and shed light on the role that the spin state may play in these reactions. Among these complexes is a highly reactive species that to date represents the closest electronic and functional model of the enzymatic intermediate, TauD-J.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.